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SHORT REPORT
TRPM7 regulates proliferation and polarisation of macrophages
Tom Schilling1, Francesc Miralles2,3 and Claudia Eder1,*
ABSTRACT
Ion channels play pivotal roles in regulating important functions of
macrophages, such as cytokine and chemokine production,
migration, proliferation, phagocytosis and others. In this study, we
have identified the transient receptor potential cation channel,
subfamily M, member 7 (TRPM7) for the first time in macrophages.
TRPM7 activity is differentially regulated in macrophages, i.e.
current density in TRPM7 is significantly larger in anti-inflammatory
M2-type macrophages than in untreated and in pro-inflammatory
M1-type macrophages, whereas mRNA levels of TRPM7 remain
unchanged upon cell polarisation. The specific TRPM7 inhibitors
NS8593 and FTY720 abolish proliferation of macrophages induced
by interleukin-4 (IL-4) and macrophage colony-stimulating factor
(M-CSF), respectively, whereas proliferation arrest was
not accompanied by induction of apoptosis or necrosis in
macrophages. Furthermore, NS8593 and FTY720 prevented
polarisation of macrophages towards the anti-inflammatory M2
phenotype. Inhibition of TRPM7 reduced IL-4-induced upregulation
of arginase-1 (Arg1) mRNA levels and Arg1 activity, and abolished
the inhibitory effects of IL-4 or M-CSF on LPS-induced TNF-a
production by macrophages. In summary, our data suggest a main
role of TRPM7 in the regulation of macrophage proliferation and
polarisation.
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INTRODUCTION
Macrophages play important roles in health and disease. Their
functions include immune surveillance, bacterial killing, tissue
remodelling and repair, clearance of cell debris and more (Gordon
and Taylor, 2005; Martinez et al., 2009; Pollard, 2009; Wynn
et al., 2013). Macrophages can have beneficial as well as
detrimental effects for the outcome of several diseases depending
on the microenvironment and activation state of the cell. A
general classification of activated macrophages into M1-type
‘classically activated’ macrophages and M2-type ‘alternatively
activated’ macrophages has been proposed recently (Martinez
et al., 2009; Sica and Mantovani, 2012; Wynn et al., 2013). M1-
type macrophages exert antimicrobial actions and promote
inflammatory processes, whereas M2-type macrophages are
involved in the resolution of inflammation and promote tissue
repair mechanisms (Martinez et al., 2009; Sica and Mantovani,
2012; Wynn et al., 2013). Although several factors have been
identified causing the transformation, i.e. polarisation, of
macrophages towards the M1 or M2 phenotype, underlying
mechanisms are poorly understood.
Over the past few years, there has been an increasing interest in
ion channels of macrophages, in particular in transient receptor
potential (TRP) channels, as they play major roles in controlling
macrophage functions, such as phagocytosis (Link et al., 2010),
production of chemokines and cytokines (Yamamoto et al., 2008;
Knowles et al., 2011), cell survival (Serafini et al., 2012). Thus,
they provide potential therapeutic targets in a variety of diseases
(Eder, 2010). The role of ion channels in regulating polarisation
of macrophages has not been addressed to date.
TRPM7 has recently been identified in a variety of tissues and
cell types, where it can have both ion channel and kinase activity.
TRPM7 is permeable to Mg2+ and Ca2+ and, thus, regulates
intracellular ion concentrations, and its protein kinase domain
mediates autophosphorylation and phosphorylates serine/
threonine residues. By regulating Mg2+ homeostasis in cells,
TRPM7 has been found to affect cellular growth and
differentiation (Harteneck, 2005; Paravicini et al., 2012). Here,
we have identified TRPM7 in macrophages, where it is involved
in the polarisation of macrophages towards the M2 phenotype as
well as in proliferation of M2 macrophages.
RESULTS AND DISCUSSION
Functional TRPM7 channels in macrophages
In a first set of experiments, ion channel expression and activity
were examined in macrophages of different activation states, for
which cells were activated either with both lipopolysaccharide
(LPS) and interferon-c (IFN-c, also known as INFG) or with
interleukin-4 (IL-4, also known as IL4). Previous in vitro
experiments have revealed that pro-inflammatory M1-type
macrophages can be induced by combined application of LPS
and IFN-c, whereas anti-inflammatory M2-type macrophages can
be induced by IL-4 (Martinez et al., 2009; Sica and Mantovani,
2012; Davis, 2013; McWhorter et al., 2013; Wynn et al., 2013).
Functional ion channels were identified using the patch clamp
technique. The most striking difference between untreated and
IL-4-stimulated M2 macrophages was found to be the activity
of TRPM7, which was increased significantly in response to
stimulation with IL-4. To evoke TRPM7-mediated currents
in macrophages, whole-cell patch clamp experiments were
performed by using Mg2+-free pipette solution. TRPM7 currents
elicited within seconds and increased in size gradually with
time, whereas stable current amplitudes were reached after 325
minutes. Fig. 1A shows typical examples of TRPM7 currents in
untreated cells, and in cells treated with IL-4 and LPS+IFN-c.
The mean TRPM7 current density of IL-4-treated macrophages
(13.662.9 pA/pF; n513 cells) was 4.7-fold higher (P,0.001)
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than that of untreated macrophages (2.960.5 pA/pF; n526 cells).
In contrast, shifting macrophages into the pro-inflammatory
M1 phenotype with LPS and IFN-c did not significantly affect
TRPM7 current density (2.660.5 pA/pF; n516 cells; P50.999)
of macrophages. Quantitative RT-PCR experiments revealed no
significant differences in expression levels of TRPM7 mRNA
between untreated macrophages and those treated with either IL-4
(P50.999) or LPS+IFN-c (P50.971) (Fig. 1B). TRPM7 currents
of macrophages were inhibited by the general TRP channel
inhibitor 2-APB, and by the TRPM7-specific inhibitors NS8593
(Chubanov et al., 2012) and FTY720 (Qin et al., 2013), as
demonstrated in Fig. 1C.
Effects of TRPM7 inhibition on proliferation of macrophages
The striking increases in the current density of TRPM7 within IL-
4-stimulated macrophages led us further to investigate the
functional importance of TRPM7 in these macrophages. First,
we tested whether IL-4-induced proliferation of macrophages was
affected by TRPM7 inhibitors. IL-4 has recently been identified
as potent stimulator of macrophage proliferation (Jenkins et al.,
2011). Compared with untreated macrophages, the proliferation
rate of macrophages treated with IL-4 for 3 days (n527
experiments; P,0.001) increased 4.8 fold. This IL-4-induced
proliferation of macrophages was completely inhibited when
TRPM7 was blocked with NS8593 (n59 experiments) or
FTY720 (n59 experiments), as demonstrated in Fig. 2A, top row.
To determine whether TRPM7 activity is required exclusively
for IL-4-induced macrophage proliferation or whether it is also
involved in macrophage proliferation induced by other stimuli,
further experiments were performed on macrophages stimulated
with macrophage colony-stimulating factor (M-CSF, also known as
CSF1) – a well-known inducer of macrophage proliferation
(Stanley et al., 1976). M-CSF induced a 13-fold increase in
macrophage proliferation rate (n539 experiments; P,0.001).
Intriguingly, the proliferation rate of macrophages treated
simultaneously with M-CSF and IL-4 was 43% lower (n512
experiments; P,0.001) than that determined for macrophages
treated with M-CSF alone (data not shown). These data are in
agreement with Arpa and colleagues, who demonstrated an
inhibition of M-CSF-stimulated proliferation by IL-4 due to
induction of p21Waf1 (Arpa et al., 2009). Similar to observations
made on IL-4-stimulated macrophages, M-CSF-induced
proliferation of macrophages was abolished by NS8593 (n59
experiments) or FTY720 (n59 experiments) (Fig. 2A, bottom row).
Next we tested whether the inhibitory effects of TRPM7
inhibitors on proliferation of macrophages were due to or
accompanied by cell death. To investigate cell apoptosis, the
combined activity of caspases 3 and 7 (caspase 3/7) – indicators
of apoptosis – was determined. As demonstrated, neither NS8593
(n59 experiments in each case) nor FTY720 (n59 experiments in
each case) induced caspase-3/7 activity in macrophages that are
treated with IL-4 (Fig. 2B, top) or M-CSF (Fig. 2B, bottom). To
investigate cell necrosis, cells were stained with ethidium
bromide. As demonstrated in Fig. 2C, macrophages cultured in
the presence of NS8593 or FTY720 did not stain positive for
ethidium bromide (n53 experiments per experimental condition).
Fig. 1. TRPM7 expression and currents in macrophages. (A,C) Macrophages were clamped at a holding potential of 230 mV and voltage ramps were
applied from 2120 mV to +120 mV for a duration of 480 ms every 20 s. (A) Current traces were recorded before (control) and after full activation of TRPM7
currents (TRPM7). Mean current densities (in pA/pF) of leak-subtracted TRPM7 currents were determined at +120 mV in untreated macrophages (n526) and in
macrophages stimulated with 20 ng/ml IL-4 (IL-4; n513) or 1 mg/ml LPS and 10 ng/ml IFN-c (LPS+IFNG; n516). (B) TRPM7 mRNA levels of macrophages kept
untreated or stimulated with 20 ng/ml IL-4 or 1 mg/ml LPS and 10 ng/ml IFN-c were determined by qPCR. (C) Current traces and corresponding current densities
of cells recorded before (control) and during activation of TRPM7 channels (TRPM7) and during superfusion of cells with 500 mM 2-APB (n55), 50 mM NS8593
(n510) or 3 mM FTY720 (n55) following TRPM7 current activation.
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Thus, it can be excluded that the NS8593- or FTY720-induced
inhibition of macrophage proliferation was caused or
accompanied by apoptotic or necrotic cell death.
Effects of TRPM7 inhibition on macrophage polarisation
In another series of experiments we asked whether TRPM7 activity
is required for the transformation of IL-4-stimulated macrophages
into the M2 phenotype. First, changes in cell morphology were
evaluated. It has recently been demonstrated that polarisation of
macrophages towards the M2 phenotype is associated with an
elongated cell shape, and that it is sufficient to prevent macrophage
elongation in order to inhibit full transformation of macrophages
to the M2 phenotype (McWhorter et al., 2013). Untreated
macrophages exhibited a roundish morphology with – in some
cases – short processes (Fig. 3A, first micrograph). In contrast,
macrophages treated with IL-4 (Fig. 3A, second micrograph) and/
or M-CSF exhibited an elongated morphology as described by
McWhorter et al., 2013. Combined treatment with IL-4 and M-CSF
induced a 2.2-fold (P,0.01) increase in the cells’ elongation factor
(not shown), whereas the factor of elongation of macrophages that
had been exposed to either IL-4 or M-CSF increased 3.5-fold
(P,0.001 in both cases) (Fig. 3A). In contrast, morphological
changes did not occur in macrophages that were treated with
NS8593 or FTY720 as well as IL-4- or M-CSF. Therefore, the
factor of elongation remained unchanged (Fig. 3A).
Because upregulation of arginase-1 (Arg1) has been identified
as a typical marker of M2-type macrophages (Sica and Mantovani,
2012), we next tested whether Arg1 mRNA expression levels and
Arg1 activity were affected by inhibition of TRPM7 in
macrophages. Both Arg1 mRNA expression levels and Arg1
activity were almost undetectable in untreated macrophages and in
LPS+IFN-c-stimulated M1-type macrophages (Fig. 3B), whereas
exposure of macrophages to IL-4 caused substantial increases in
Arg1 mRNA levels and Arg1 activity (P,0.001 in both cases)
(Fig. 3B). In the presence of NS8593, Arg1 mRNA levels and Arg1
activity of IL-4 stimulated macrophages were reduced by 89.5%
(n58 experiments; P,0.001) and 45.4% (n56 experiments;
P,0.01), respectively (Fig. 3B).
To further test whether blocking of TRPM7 activity affects
macrophage polarisation, LPS-induced release of TNF-a was
determined. In control cells that had been cultured without any
pre-treatment, stimulation with LPS caused substantial (n54
experiments; P,0.05) release of TNF-a (Fig. 3C, left graph,
second column). In contrast, M2-type macrophages pre-treated
with IL-4 for 3 days failed to produce TNF-a following
subsequent stimulation with LPS. However, TNF-a production
could be induced by LPS in macrophages pre-treated with IL-4 in
the presence of TRPM7 inhibitors (Fig. 3C). TNF-a production
by LPS-stimulated macrophages pre-treated with IL-4 in the
presence of TRPM7 inhibitors did not differ significantly (n53
experiments, P50.377 for NS8593; n53 experiments, P50.654
for FTY720) from that of LPS-stimulated control macrophages.
Similarly, macrophages pre-exposed to M-CSF – which can also
induce the anti-inflammatory M2-like phenotype in macrophages
(Lacey et al., 2012) – were unable to produce significant levels of
TNF-a in response to stimulations with LPS, whereas levels of
TNF-a increased in LPS-stimulated macrophages when TRPM7
was inhibited by NS8593 or FTY720 (Fig. 3C).
Conclusions
This is the first study to demonstrate presence, regulation and
functional importance of TRPM7 in macrophages. We have
Fig. 2. Inhibitory effects of TRPM7 inhibitors on macrophage proliferation. (A) Proliferation of macrophages was induced by either IL-4 or M-CSF, in
absence or presence of TRPM7 blockers as indicated. (B) No activity of caspase 3/7 was found in macrophages treated with IL-4 or M-CSF in absence or
presence of NS8593 or FTY720, indicating absence of apoptosis. As positive control (p.c.), macrophages were exposed to 5 mM staurosporine for 24 h in each
experimental condition. (C) TRPM7 inhibitors have no effect on macrophage necrosis determined as percentage of ethidium bromide (EB)-positive cells. As
positive control (p.c.), cells were damaged by freezing and subsequent thawing. (A-C) Macrophages were kept untreated or were treated with 20 ng/ml IL-4 and/
or 50 ng/ml M-CSF in absence or presence of 50 mM NS8593 or 3 mM FTY720, as indicated.
SHORT REPORT Journal of Cell Science (2014) 127, 4561–4566 doi:10.1242/jcs.151068
4563
Jo
ur
na
l o
f C
el
l S
ci
en
ce
identified two main functions of TRPM7 in macrophages: (1) their
role in the regulation of macrophage proliferation and (2)
their requirement for the polarisation of M2-type macrophages.
Our data suggest that proliferating M2-type macrophages are
characterised by enhanced TRPM7 activity, which is required for
optimal proliferation of macrophages, independently of the stimulus
causing macrophage proliferation. To our knowledge, this is the
first description of functional TRPM7 in macrophages. Although
mRNA expression levels of TRPM7 remained unchanged, the
TRPM7 current density was increased following treatment of
macrophages with IL-4. These data suggest that IL-4 does not affect
TRPM7 expression, but rather modulates the activity of this cation
channel, possibly regulating the influx of Mg2+ and Ca2+ at
physiological membrane potentials (Harteneck, 2005; Paravicini
et al., 2012). Both, Mg2+ and Ca2+ are essential for optimal
proliferation of other cell types (Wolf et al., 2008; Machaca, 2011).
It has been suggested that Mg2+ is implicated in several processes,
e.g. gene transcription and protein synthesis, DNA duplication, and
cytoskeletal rearrangement (Wolf et al., 2008). Ca2+ regulates a
wide variety of cell functions, modulates intracellular signalling
pathways, regulates gene expression and has a role during various
stages of the cell cycle (Machaca, 2011). Owing to the variety of
Mg2+- and Ca2+-regulated cell processes, the precise role of Mg2+
and/or Ca2+ in cell cycle progression in macrophages that have been
stimulated with IL-4- and M-CSF remains to be elucidated.
In addition to the importance of TRPM7 in macrophage
proliferation, we established that TRPM7 has a role in regulating
the functional state of macrophages. TRPM7 blockers can inhibit
IL-4- or M-CSF-induced changes of cell morphology, upregulation
of Arg1 mRNA expression and upregulation of Arg1 activity.
Furthermore, TRPM7 inhibitors prevent the inhibitory effect that
IL-4 or M-CSF have on the production of the pro-inflammatory
cytokine TNF-a. Together, these data suggest that TRPM7 activity
is required for polarisation of macrophages towards the
Fig. 3. Inhibitory effects of TRPM7 inhibitors on
macrophage polarisation. (A) Micrographs show
examples of brightfield DIC of IL-4-treated
macrophages in the absence and presence of
TRPM7 inhibitors. Graphs show the factor of
elongation for untreated macrophages, or
macrophages treated with IL-4 or M-CSF with or
without additional treatment of TRPM7 inhibitors as
indicated. (B) Inhibitory effects of NS8593 on Arg1
expression and Arg1 activity of IL-4-treated
macrophages. Normalised Arg1 mRNA levels (left)
and Arg1 activity (right) determined in macrophages
kept untreated or stimulated with LPS/IFN-c or IL-4
in absence or presence of NS8593 as indicated.
(C) TNF-a release from macrophages stimulated
with 1 mg/ml LPS for 4 h. Prior to LPS stimulation,
macrophages had not been cultured as normal
(untreated) or had been pre-treated with IL-4 in
absence or presence of NS8593 or FTY720 as
indicated. (A-C) Macrophages were cultured with or
without additional treatment of 20 ng/ml IL-4 or
50 ng/ml M-CSF in absence or presence of 50 mM
NS8593 or 3 mM FTY720 for 3 days as indicated.
SHORT REPORT Journal of Cell Science (2014) 127, 4561–4566 doi:10.1242/jcs.151068
4564
Jo
ur
na
l o
f C
el
l S
ci
en
ce
anti-inflammatory M2 phenotype. To our knowledge, this is the
first study that investigated the role of an ion channel in the
regulation of macrophage polarisation. Why is TRPM7 activity
required for the polarisation of macrophages? To date it can only
be speculated regarding the importance of TRPM7 activity for the
transformation of macrophages into the M2 phenotype. It has been
found recently that inhibition of TRPM7 decreases
phosphorylation of PI3K and ERK1 and ERK2 (MAPK3 and
MAPK1, respectively) in hepatic stellate cells (Fang et al., 2013).
Since PI3K/ERK phosphorylation appears to be required for
polarisation of macrophages towards the M2 phenotype (Zhang
et al., 2011), it is possible that, in macrophages, TRPM7 activity
modulates intracellular pathways, such as PI3K/AKT/ERK
signalling, that are involved in M2 macrophage polarisation.
Further experiments are required to elucidate the precise
mechanism by which inhibition of TRPM7 affects macrophage
polarisation towards the M2 phenotype.
MATERIALS AND METHODS
Macrophage cultures
C57Bl/6 mice were supplied by Charles River (Margate, UK). Bone-
marrow-derived macrophages were prepared as described previously
(Eder and Fischer, 1997) with minor modifications. Briefly, bone marrow
cells, flushed from femur and tibia with ice-cold PBS, were resuspended
for 2 minutes in 155 mM NH4Cl solution to lyse erythrocytes. The
remaining leukocytes were seeded at 66106 cells/10 ml in uncoated Petri
dishes. Culture medium was Dulbecco’s modified Eagle medium
(DMEM; LifeTechnologies, Paisley, UK) containing additionally 2 mM
L-glutamine and 10% heat-inactivated fetal calf serum (FCS)
(LifeTechnologies). The culture medium was changed on days 2 and 5.
To support outgrowth of macrophages, the medium was supplemented
with 30% supernatant of L-929 fibroblast cultures as a source of M-CSF.
On day 8, adherent cells were harvested and subcultured in DMEM/
10%FCS (LifeTechnologies) for experiments. Macrophages were
maintained for 3 days in the absence or presence of 20 ng/ml IL-4 and/
or 50 ng/ml M-CSF with or without 50 mM NS8593 or 3 mM FTY720 as
indicated. In some cases, macrophages were cultured for 1 day in
DMEM/10%FCS containing 1 mg/ml LPS and 10 ng/ml IFN-c. This
study was performed in accordance with the Animals (Scientific
Procedures) Act 1986 under regulations from the Home Office England.
Chemicals
The following drugs were used in this study: IL-4, M-CSF, IFN-c (all
from R&D systems, Abingdon, UK), LPS, 2-APB, staurosporine, N-
[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]-1H-benzimidazol-2-amine hydro-
chloride (NS8593) (all from Sigma-Aldrich, Dorset, UK), FTY720
hydrochloride (FTY720; Cayman Europe, Tallin, Estonia).
Electrophysiological recordings
For patch clamp experiments, 26105 cells per well were seeded on
uncoated glass coverslips in 24-well tissue culture plates and cultured as
indicated. Whole-cell membrane currents were measured using a patch
clamp recording system as described previously (Schilling and Eder,
2009). The intracellular solution (pH 7.3) contained: 20 mM NaCl, 100
mM Na-D-gluconate, 1 mM CaCl2, 10 mM HEPES, 11 mM EGTA. The
extracellular solution (pH 7.4) contained: 135 mM NaCl, 2 mM CaCl2, 1
mM MgCl2, 10 mM HEPES, 10 mM D-glucose.
Proliferation assay
To determine proliferation rates, 16104 cells per well were plated in
black 96-well clear, flat-bottomed tissue culture plates and cultured as
indicated. Proliferation of macrophages was determined by CyQUANT
proliferation assay (LifeTechnologies) according to the manufacturer’s
instructions. Fluorescence intensity for each well was measured using a
microplate reader (FLUOstar Omega, BMG Labtech, Aylesbury, UK)
equipped with a 500610 nm excitation filter and a 530610 nm emission
filter. Background-corrected data were collected in at least three
independent experiments from at least three different wells.
Apoptosis assay
To determine apoptosis, 16104 cells per well were seeded in black 96-
well plates and cultured as indicated. Activity of caspases 3 and 7
(caspase 3/7) as a measure of cell apoptosis was assessed using CellEvent
Caspase-3/7 Green Detection Reagent (LifeTechnologies) according to
the manufacturer’s instructions. Fluorescence intensity of cells was
detected using a microplate reader (FLUOstar Omega, BMG Labtech),
which was equipped with a 500610 nm excitation and a 530610 nm
emission filter. Background-corrected data were collected in at least three
independent experiments from at least three wells. All data were
normalised to the mean cell count determined for each experimental
condition by the CyQUANT proliferation assay.
Necrosis assay
Membrane integrity of macrophages was investigated using ethidium
bromide (LifeTechnologies) staining as described previously (Schilling
et al., 2004). Images of at least three different visual fields for at
least three independent experiments per condition were collected and
analysed.
Analysis of cell morphology
To quantify changes in macrophage morphology, the factor of
elongation was determined as described previously (McWhorter
et al., 2013). In brief, macrophages were plated at a density of
1.56105 cells on glass coverslips in 24-well plates and cultured as
indicated. Subsequently, cells were fixed for 5 min with 2%
paraformaldehyde and 0.2% glutaraldehyde. After washing cells
twice with PBS, brightfield pictures were taken and analysed using
the programme ImageJ (NIH, Bethesda, MA). The factor of elongation
was determined for each individual macrophage by dividing the length
of the longest axis by the length of the shortest axis across the cell
nucleus.
Arginase assay
To determine Arg1 activity, 16106 cells per well were plated in six-well
tissue culture dishes and cultured as indicated. Subsequently, Arg1 activity
in cell lysates and culture supernatants was assayed using QuantiChrom
Arginase Assay kit (BioAssay Systems, Hayward, CA) according to the
manufacturer’s instructions. For each experimental condition, Arg1
activity was normalised to protein concentration, which was determined
from cell pellets using a Micro BCA protein assay kit (ThermoScientific,
Rockford, IL) according to the manufacturer’s protocol.
Detection of TNF-a by ELISA
Macrophages were plated in six-well culture dishes at a density of 16106
cells per well and cultured as indicated. Thereafter, cell supernatants
were collected and stored at 280 C˚. To determine concentrations of
tumour necrosis factor alpha (TNF-a) in supernatants of macrophages,
murine TNF-a Quantikine Immunoassay kit (R&D systems, Abingdon,
UK) was used according to the manufacturer’s instructions. The
sensitivity of the TNF-a sandwich ELISA kit was 5 pg/ml.
Quantitative RT-PCR
RNA was purified with the E.Z.N.A Total RNA kit (Omega Bio-tek,
Norcross, GA). RNA was DNase I treated in-column during the
purification process and 500 ng RNA were reverse transcribed using
random hexamers and Maxima reverse transcriptase according to the
manufacturer’s instructions (Fisher Scientific, Hampton, USA).
Quantitative PCR was conducted on a C1000 Thermal Cycler (Biorad,
Hercules, CA) with 30 ng of reverse transcribed RNA and DyNAmo
Flash SYBR Green qPCR mix (Thermo Scientific, Walham, MA) using
the following mouse-specific primers: Arg-1, forward: 59-CTCCAAG-
CCAAAGTCCTTAGAG-39; Reverse, 59-AGGAGCTGTCATTAGGG-
ACATC-39), TRPM7, forward: 59-AGGATGTCAGATTTGTCAGCAA-
39; reverse: 59-CCTGGTTAAAGTGTTCACCCAA-39). Primers for the
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ribosomal protein L7 RNA were used as a control and have been
described previously (Perdiguero et al., 2007).
Statistics
All data are presented as mean values 6 standard error of the mean
(6s.e.m.) and numbers of analysed samples are indicated. The statistical
significance of differences between experimental groups was evaluated
either by paired t-tests (analysis of drug effects on TRPM7 currents) or by
one-way ANOVA (all other experiments) using SPSSv19. Tukey’s test
was used for post hoc comparison after confirming homogeneity of
variances with Levene’s test. Data were considered to be statistically
significant with P,0.05.
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